| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |